Gufic Biosciences Ltd - 509079 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 (6) read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the details of the scheduled meeting with the Analyst/Investor, is enclosed herewith. Kindly take the same on record. GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Further to our communication dated August 13, 2021 on Earning Conference Call and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, written transcript of the said call held on August 12, 2021 at 5.00 p.m. has been uploaded on the Company's website and can be accessed through the link: http://gufic.com/Notice/Written%20Transcript.pdf Kindly take the same on record. GUFIC BIOSCIENCES LTD. - 509079 - Audio Recording Of Earnings Conference Call Conducted On August 12, 2021
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)Regulations 2015, audio call recording of the earnings call held on 12th August, 2021 at 5:00 p.m. has been uploaded on the Company's website and can be accessed through the link: http://gufic.com/Notice/AUDIORECORDING_12082021.mp3 Written transcript of the same will be submitted in due course. Kindly take the same on record. Gufic Biosciences Ltd - 509079 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors
The Board of Directors of the Company at its Meeting held on August 11, 2021, which commenced at 4.00 p.m. and concluded at 7.40 p.m., inter alia considered and approved the following: 1. The Un-Audited Financial Results for the quarter ended June 30, 2021 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 2. The Board of Directors on the recommendation of the Nomination and Remuneration Committee, subject to the approval of shareholders at the ensuing Annual General Meeting approved re-appointment of Dr. Anu Aurora (DIN: 05120192) as an Independent Director of the Company, whose current term will expire on December 22, 2021 for a second term of 5 (Five) consecutive years commencing from December 23, 2021 to December 22, 2026 (both days inclusive). Gufic Biosciences Ltd - 509079 - Results - Financial Results For Quarter Ended June 30, 2021
The Board of Directors of the Company at its Meeting held on August 11, 2021, inter alia considered and approved the Un-Audited Financial Results for the quarter ended June 30, 2021 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Enclosed herewith is the copy of the Un-Audited Financial Results for the Quarter ended June 30, 2021 along with Limited Review Report received from the Statutory Auditor of the Company on the Un-Audited Financial Results for the Quarter ended June 30, 2021, Management Report and the Investor Presentation giving highlights of the Company's performance during the said quarter. GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
In partial modification of our earlier intimation dated August 09, 2021 pertaining to the Earnings Conference Call scheduled for Investor/Analyst on Thursday, August 12, 2021, please be informed that the mode and the time of the call has been revised and the revised schedule of the said call is enclosed herewith, for your information and records. GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
In partial modification of our earlier intimation dated August 09, 2021 pertaining to the Earnings Conference Call scheduled for Investor/Analyst on Thursday, August 12, 2021, please be informed that the mode and the time of the call has been revised and the revised schedule of the said call is enclosed herewith, for your information and records. Gufic Biosciences Ltd - 509079 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Company will host an Earnings Call (Virtual) for Investors/Analysts on Thursday, August 12, 2021, at 16:00 hours (IST), during which officials of the Company will discuss the business background/prospects and financial performance of the Company and take questions. Gufic Biosciences Ltd - 509079 - Board Meeting Intimation for For Consideration And Approval Of Un-Audited Financial Results Of The Company For The Quarter Ended June 30, 2021.
GUFIC BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2021 ,inter alia, to consider and approve Pursuant to the provisions of Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, August 11, 2021, inter alia, to consider and approve the Un-Audited Financial Results of the Company for the quarter ended June 30, 2021. Further, pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 and as per the terms of the Code of Conduct of the Company, the trading window for dealing in securities of the Company which is closed from Thursday, July 01, 2021 shall continue to remain closed and shall re-open on the expiry of 48 hours from the declaration of the financial results for the said quarter.
